UTI AMC Intrinsic Value
UTIAMC Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹423.36 | ₹338.69 - ₹508.03 | -55.8% | EPS: ₹35.28, Sector P/E: 12x |
| Book Value Method | asset | ₹403.12 | ₹362.81 - ₹443.43 | -57.9% | Book Value/Share: ₹403.12, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹287.59 | ₹258.83 - ₹316.35 | -70.0% | Revenue/Share: ₹131.56, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹383.46 | ₹345.11 - ₹421.81 | -60.0% | EBITDA: ₹720.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹568.80 | ₹455.04 - ₹682.56 | -40.7% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹287.59 | ₹258.83 - ₹316.35 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹290.71 | ₹261.64 - ₹319.78 | -69.7% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹495.00 | ₹445.50 - ₹544.50 | -48.4% | ROE: 10.2%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹565.69 | ₹509.12 - ₹622.26 | -41.0% | EPS: ₹35.28, BVPS: ₹403.12 |
Want to compare with current market value? Check UTIAMC share price latest .
Valuation Comparison Chart
UTIAMC Intrinsic Value Analysis
What is the intrinsic value of UTIAMC?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of UTI AMC (UTIAMC) is ₹403.12 (median value). With the current market price of ₹958.65, this represents a -57.9% variance from our estimated fair value.
The valuation range spans from ₹287.59 to ₹568.80, indicating ₹287.59 - ₹568.80.
Is UTIAMC undervalued or overvalued?
Based on our multi-method analysis, UTI AMC (UTIAMC) appears to be trading above calculated value by approximately 57.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.63 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 10.2% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 42.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.30x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for UTI AMC
Additional stock information and data for UTIAMC
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹536 Cr | ₹536 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹325 Cr | ₹252 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹395 Cr | ₹349 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹337 Cr | ₹307 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹153 Cr | ₹125 Cr | Positive Free Cash Flow | 8/10 |